Induction of MIC-1/growth differentiation factor-15 following bile duct injury

Journal of Gastrointestinal Surgery

Volumn 7, Issue 7, 2003, Pages 901-905

  Koniaris, Leonidas G ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cholangiocarcinoma; Cytokines; Growth substances; Inflammation

Indexed keywords

DIFFERENTIATION INDUCING FACTOR; GROWTH DIFFERENTIATION FACTOR 15; MACROPHAGE MIGRATION INHIBITION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT INJURY; BILE DUCT LIGATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE INDUCTION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER; LIVER CELL; LIVER CIRRHOSIS; MALE; MEDIATOR; MOUSE; NONHUMAN; NORTHERN BLOTTING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; SCLEROSING CHOLANGITIS; TIME; TISSUE SECTION;

EID: 0242270772     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(03)00151-3     Document Type: Article

References (25)

1. Albertoni M., Shaw P.H., Nozaki M., et al. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene. 21:2002;4212-4219.
2. Bootcov M.R., Bauskin A.R., Valenzuela S.M., et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A. 94:1997;11514-11519.
3. Hsiao E.C., Koniaris L.G., Zimmers-Koniaris T., et al. Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol. 20:2000;3742-3751.
4. Hromas R., Hufford M., Sutton J., et al. PLAB, a novel placental bone morphogenetic protein. Biochim Biophys Acta. 1354:1997;40-44.
5. Kannan K., Amariglio N., Rechavi G., Givol D. Profile of gene expression regulated by induced p53: Connection to the TGF-beta family. FEBS Lett. 470:2000;77-82.
6. Yokoyama-Kobayashi M., Saeki M., Sekine S., Kato S. Human cDNA encoding a novel TGF-beta superfamily protein highly expressed in placenta. J Biochem (Tokyo). 122:1997;622-626.
7. Paralkar V.M., Vail A.L., Grasser W.A., et al. Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J Biol Chem. 273:1998;13760-13767.
8. Lawton L.N., Bonaldo M.F., Jelenc P.C., et al. Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. Gene. 203:1997;17-26.
9. Schober A., Bottner M., Strelau J., et al. Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol. 439:2001;32-45.
10. Brown D.A., Breit S.N., Buring J., et al. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: A nested case-control study. Lancet. 359:2002;2159-2163.
11. Bottner M., Laaff M., Schechinger B., et al. Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1). Gene. 237:1999;105-111.
12. Tan M., Wang Y., Guan K., Sun Y. PTGF-beta a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc Natl Acad Sci U S A. 97:2000;109-114.
13. Markowitz S.D., Roberts A.B. Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev. 7:1996;93-102.
14. Schulick A.H., Taylor A.J., Zuo W., et al. Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci U S A. 95:1998;6983-6988.
15. Li P.X., Wong J., Ayed A., et al. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem. 275:2000;20127-20135.
16. Baek S.J., Wilson L.C., Lee C.H., Eling T.E. Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): Inhibition of cyclooxygenase and induction of NSAID-activated gene. J Pharmacol Exp Ther. 301:2002;1126-1131.
17. Baek S.J., Wilson L.C., Eling T.E. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis. 23:2002;425-434.
18. Bottone F.G. Jr., Baek S.J., Nixon J.B., Eling T.E. Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. J Nutr. 132:2002;773-778.
19. Strelau J., Bottner M., Lingor P., et al. GDF-15/MIC-1 a novel member of the TGF-beta superfamily. J Neural Transm Suppl. 60:2000;273-276.
20. Baek S.J., Horowitz J.M., Eling T.E. Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J Biol Chem. 276:2001;33384-33392.
21. Koniaris L.G., Zimmers-Koniaris T., Hsiao E.C., et al. Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol. 167:2001;399-406.
22. Esquela A.F., Zimmers T.A., Koniaris L.G., et al. Transient down-regulation of inhibin-betaC expression following partial hepatectomy. Biochem Biophys Res Commun. 235:1997;553-556.
23. Zimmers T.A., Davies M.V., Koniaris L.G., et al. Induction of cachexia in mice by systemically administered myostatin. Science. 296:2002;1486-1488.
24. Kim K.S., Baek S.J., Flake G.P., et al. Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology. 122:2002;1388-1398.
25. Koniaris L.G., McKillop I.H., Schwartz S.I., Zimmers T.A. Liver regeneration. J Am Coll Surgeons. 2003;. (in press).